Stajer M, Horacek J, Kupsa T, Zak P
J Appl Biomed. 2025; 22(4):165-184.
PMID: 40033805
DOI: 10.32725/jab.2024.024.
Fei F, Zhang M, Tarighat S, Joo E, Yang L, Heisterkamp N
Int J Mol Sci. 2022; 23(22).
PMID: 36430839
PMC: 9694201.
DOI: 10.3390/ijms232214359.
Tarighat S, Fei F, Joo E, Abdel-Azim H, Yang L, Geng H
Int J Mol Sci. 2021; 22(22).
PMID: 34830047
PMC: 8624256.
DOI: 10.3390/ijms222212167.
Cancilla D, Rettig M, Dipersio J
Front Oncol. 2020; 10:1672.
PMID: 33014834
PMC: 7499473.
DOI: 10.3389/fonc.2020.01672.
Wang S, Wang X, Liu S, Zhang S, Wei X, Song Y
Onco Targets Ther. 2020; 13:6583-6591.
PMID: 32753894
PMC: 7352451.
DOI: 10.2147/OTT.S249425.
Three-dimensional tumor model mimics stromal - breast cancer cells signaling.
Ham S, Shahi Thakuri P, Plaster M, Li J, Luker K, Luker G
Oncotarget. 2018; 9(1):249-267.
PMID: 29416611
PMC: 5787462.
DOI: 10.18632/oncotarget.22922.
CXCR4 antagonists suppress small cell lung cancer progression.
Taromi S, Kayser G, Catusse J, von Elverfeldt D, Reichardt W, Braun F
Oncotarget. 2016; 7(51):85185-85195.
PMID: 27835905
PMC: 5356728.
DOI: 10.18632/oncotarget.13238.
Chimeric Mouse model to track the migration of bone marrow derived cells in glioblastoma following anti-angiogenic treatments.
Achyut B, Shankar A, Iskander A, Ara R, Knight R, Scicli A
Cancer Biol Ther. 2016; 17(3):280-90.
PMID: 26797476
PMC: 4847989.
DOI: 10.1080/15384047.2016.1139243.
Delivery of siRNA Using CXCR4-targeted Nanoparticles Modulates Tumor Microenvironment and Achieves a Potent Antitumor Response in Liver Cancer.
Liu J, Chiang T, Liu C, Chern G, Lin T, Gao D
Mol Ther. 2015; 23(11):1772-1782.
PMID: 26278330
PMC: 4817943.
DOI: 10.1038/mt.2015.147.
A CXCR4-targeted site-specific antibody-drug conjugate.
Kularatne S, Deshmukh V, Ma J, Tardif V, Lim R, Pugh H
Angew Chem Int Ed Engl. 2014; 53(44):11863-7.
PMID: 25213874
PMC: 4331128.
DOI: 10.1002/anie.201408103.
Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia.
Bernt K, Hunger S
Front Oncol. 2014; 4:54.
PMID: 24724051
PMC: 3971203.
DOI: 10.3389/fonc.2014.00054.
Imaging CXCL12-CXCR4 signaling in ovarian cancer therapy.
Salomonnson E, Stacer A, Ehrlich A, Luker K, Luker G
PLoS One. 2013; 8(1):e51500.
PMID: 23372646
PMC: 3553093.
DOI: 10.1371/journal.pone.0051500.
Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxin.
Parameswaran R, Yu M, Lyu M, Lim M, Rosenblum M, Groffen J
Leukemia. 2012; 26(8):1786-96.
PMID: 22373785
PMC: 3376225.
DOI: 10.1038/leu.2012.54.
5T4 oncofetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotype.
Castro F, McGinn O, Krishnan S, Marinov G, Li J, Rutkowski A
Leukemia. 2012; 26(7):1487-98.
PMID: 22266911
PMC: 3378689.
DOI: 10.1038/leu.2012.18.
